Subscribe free

HPB & Spleen ·

Portal Vein Resection in Pancreatic Neuroendocrine Neoplasms

Portal vein resection in surgery for pancreatic neuroendocrine neoplasms was analyzed in this study. Among 666 patients, 8% underwent portal vein resection. Postoperative complications were comparable to standard resection, with a low 90-day mortality rate. Radical resection resulted in excellent 5-year overall and disease-specific survival rates. This study provides valuable data on the perioperative and long-term outcomes of portal vein resection, supporting its use as a potential cure for borderline resectable or locally advanced pancreatic neuroendocrine neoplasms.

Journal Article by Nießen A, Klaiber U (…) Hackert T et 5 al. in BMC Surg

Copyright © 2023 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →